Helmut Mack

This inventor holds 44 USPTO granted patents and 13 published patent applications and 11 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc., Abbott Gmbh & Co Kg. Active years: 1996-2018.

USPTO Granted Patents = 44 (Patent Applications = 13)

% Patents Active = 43.2

EPO Patents = 11 (Patent Applications = 21)

Average Co-Inventor Count = 7.9

ph-index = 10

Forward Citations = 227(Granted Patents)

Location History:

Meckenheim, DE (1996)
Wiesbaden, DE (2015 - 2016)
Ludwigshafen, DE (1998 - 2018)

Company Filing History:

17 out of 167

Abbvie Deutschland Gmbh and Co Kg

Basf Aktiengesellschaft

patents

5. 6 out of 4,186

Abbott Laboratories Corporation

patents

where one patent can have more than one assignee

Years Active: 1996-2018

Loading Chart...

Areas of Expertise:

Calpain Inhibitors

Thrombin Inhibitors

Kinase Inhibitors

Heterocyclic Compounds

Quinoline Derivatives

Glycogen Synthase Kinase-3

NAMPT Inhibitors

4-(4-Pyridinyl)-Benzamides

Indazoles

Calcium Channel Blockers

Dipeptide Benzamidine

Prodrugs

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10118926 - Tricyclic quinoline and quinoxaline derivatives (2018-11-06),

2. 10093624 - NAMPT and ROCK inhibitors (2018-10-09),

3. 9994568 - Tricyclic quinoline and quinoxaline derivatives (2018-06-12),

4. 9573950 - Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators (2017-02-21),

5. 9567325 - Carboxamide compounds and their use as calpain inhibitors (2017-02-14),

6. 9540376 - Hexahydrodiazepinoquinolines carrying a substituted alkyl radical (2017-01-10),

7. 9540370 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2017-01-10),

8. 9527811 - Carboxamide compounds and their use as calpain inhibitors (2016-12-27),

9. 9302989 - NAMPT and rock inhibitors (2016-04-05),

10. 9169253 - Tricyclic quinoline and quinoxaline derivatives (2015-10-27),

11. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

12. 9150553 - Carboxamide compounds and their use as calpain inhibitors (2015-10-06),

13. 9150545 - Carboxamide compounds and their use as calpain inhibitors V (2015-10-06),

14. 9139557 - Carboxamide compounds and their use as calpain inhibitors (2015-09-22),

15. 9090592 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2015-07-28),

Title: Helmut Mack - Pioneering Inventor from Ludwigshafen

Introduction: Helmut Mack is a renowned inventor hailing from Ludwigshafen, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Helmut Mack's latest patents include advancements in renewable energy technologies, sustainable materials, and cutting-edge manufacturing processes.

Career Highlights: Throughout his illustrious career, Helmut Mack has received numerous accolades for his innovative work, including several prestigious awards for his impactful inventions that have revolutionized various industries.

Collaborations: Helmut Mack has collaborated with leading research institutions, universities, and multinational companies to further develop and implement his pioneering ideas, showcasing his ability to work across diverse sectors.

Conclusion: Helmut Mack's dedication to pushing the boundaries of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor in Ludwigshafen and beyond.